NO920855L - Medikamentinneholdende matrise - Google Patents
Medikamentinneholdende matriseInfo
- Publication number
- NO920855L NO920855L NO92920855A NO920855A NO920855L NO 920855 L NO920855 L NO 920855L NO 92920855 A NO92920855 A NO 92920855A NO 920855 A NO920855 A NO 920855A NO 920855 L NO920855 L NO 920855L
- Authority
- NO
- Norway
- Prior art keywords
- patient
- lollipop
- drug
- lipophilic
- medicine
- Prior art date
Links
- 239000011159 matrix material Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 abstract 4
- 239000003814 drug Substances 0.000 abstract 4
- 235000011475 lollipops Nutrition 0.000 abstract 4
- 230000000694 effects Effects 0.000 abstract 2
- 230000002686 anti-diuretic effect Effects 0.000 abstract 1
- 230000003474 anti-emetic effect Effects 0.000 abstract 1
- 230000000843 anti-fungal effect Effects 0.000 abstract 1
- 230000002460 anti-migrenic effect Effects 0.000 abstract 1
- 230000000648 anti-parkinson Effects 0.000 abstract 1
- 230000001262 anti-secretory effect Effects 0.000 abstract 1
- 229940124538 antidiuretic agent Drugs 0.000 abstract 1
- 239000003160 antidiuretic agent Substances 0.000 abstract 1
- 239000002111 antiemetic agent Substances 0.000 abstract 1
- 229940121375 antifungal agent Drugs 0.000 abstract 1
- 239000000939 antiparkinson agent Substances 0.000 abstract 1
- 229940124630 bronchodilator Drugs 0.000 abstract 1
- 230000002218 hypoglycaemic effect Effects 0.000 abstract 1
- -1 hypoglycemic Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Reproductive Health (AREA)
- Oncology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1989/003801 WO1991003233A1 (en) | 1989-09-05 | 1989-09-05 | Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO920855D0 NO920855D0 (no) | 1992-03-04 |
| NO920855L true NO920855L (no) | 1992-04-10 |
Family
ID=22215208
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO92920855A NO920855L (no) | 1989-09-05 | 1992-03-04 | Medikamentinneholdende matrise |
| NO92920854A NO920854L (no) | 1989-09-05 | 1992-03-04 | Fremgangsmaate og sammensetninger for ikke-invasiv dose til effekt-administrering av lipofile medikamenter |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO92920854A NO920854L (no) | 1989-09-05 | 1992-03-04 | Fremgangsmaate og sammensetninger for ikke-invasiv dose til effekt-administrering av lipofile medikamenter |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0493380B1 (de) |
| JP (1) | JP2758985B2 (de) |
| AT (1) | ATE159658T1 (de) |
| AU (2) | AU645966B2 (de) |
| DE (1) | DE68928415T2 (de) |
| DK (1) | DK175773B1 (de) |
| NO (2) | NO920855L (de) |
| WO (1) | WO1991003233A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH624011A5 (de) * | 1977-08-05 | 1981-07-15 | Battelle Memorial Institute | |
| DK0745380T3 (da) * | 1995-05-11 | 2005-12-05 | Univ Utah Res Found | Tobakserstatning |
| US20060051413A1 (en) * | 2004-09-08 | 2006-03-09 | Chow Sing S M | Method of enhancing absorptions of transmucosal administration formulations |
| WO2007090113A2 (en) * | 2006-02-01 | 2007-08-09 | Weg Stuart L | Use of antifungal compositions to treat upper gastrointestinal conditions |
| US20160022643A1 (en) * | 2014-07-22 | 2016-01-28 | Professional Compounding Centers Of America | Oral Transmucosal Compositions including Aromatase Inhibitors for Low Testosterone Levels in Men |
| EP3200773B1 (de) | 2014-10-01 | 2018-07-18 | Oxytone Bioscience B.V. | Im mund zerfallende feste pharmazeutische dosiereinheit mit partuskontrollsubstanz |
| ES2821822T3 (es) | 2014-10-01 | 2021-04-27 | Oxytone Bioscience B V | Unidad de dosificación farmacéutica sólida desintegrante por vía oral que contiene una sustancia de control de partos |
| GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| US12459965B2 (en) | 2017-10-09 | 2025-11-04 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
| CA3138094A1 (en) | 2019-04-17 | 2020-10-22 | Compass Pathfinder Limited | Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2208120A (en) * | 1938-03-02 | 1940-07-16 | William B Coleman | Pharmaceutical preparation and method of making same |
| US3943928A (en) * | 1974-09-25 | 1976-03-16 | Lariccia Anthony H | Eliminating the safety hazard in oral dissolution of a solid |
| CA1208558A (en) * | 1982-10-07 | 1986-07-29 | Kazuo Kigasawa | Soft buccal |
| US4551329A (en) * | 1984-01-20 | 1985-11-05 | Joan Harris | Oral medicament lollipop |
| US4671953A (en) | 1985-05-01 | 1987-06-09 | University Of Utah Research Foundation | Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics |
-
1989
- 1989-09-05 DE DE68928415T patent/DE68928415T2/de not_active Expired - Lifetime
- 1989-09-05 JP JP2502779A patent/JP2758985B2/ja not_active Expired - Lifetime
- 1989-09-05 EP EP90902584A patent/EP0493380B1/de not_active Expired - Lifetime
- 1989-09-05 AT AT90902584T patent/ATE159658T1/de not_active IP Right Cessation
- 1989-09-05 AU AU50352/90A patent/AU645966B2/en not_active Ceased
- 1989-09-05 WO PCT/US1989/003801 patent/WO1991003233A1/en not_active Ceased
-
1992
- 1992-03-04 NO NO92920855A patent/NO920855L/no unknown
- 1992-03-04 NO NO92920854A patent/NO920854L/no unknown
- 1992-03-05 DK DK199200300A patent/DK175773B1/da not_active IP Right Cessation
-
1994
- 1994-04-27 AU AU60697/94A patent/AU6069794A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DK175773B1 (da) | 2005-02-14 |
| NO920854L (no) | 1992-04-27 |
| DE68928415D1 (de) | 1997-12-04 |
| AU6069794A (en) | 1994-06-23 |
| NO920854D0 (no) | 1992-03-04 |
| WO1991003233A1 (en) | 1991-03-21 |
| NO920855D0 (no) | 1992-03-04 |
| DK30092A (da) | 1992-05-05 |
| DE68928415T2 (de) | 1998-02-26 |
| EP0493380B1 (de) | 1997-10-29 |
| AU645966B2 (en) | 1994-02-03 |
| AU5035290A (en) | 1991-04-08 |
| EP0493380A4 (en) | 1992-10-07 |
| JP2758985B2 (ja) | 1998-05-28 |
| DK30092D0 (da) | 1992-03-05 |
| ATE159658T1 (de) | 1997-11-15 |
| EP0493380A1 (de) | 1992-07-08 |
| JPH05501854A (ja) | 1993-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9401406D0 (sv) | Pharmaceutical products for curing tumourous diseases and process for preparing same | |
| Kennedy et al. | Intravenous regional analgesia: an appraisal | |
| DE69815122D1 (de) | Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen | |
| UY26425A1 (es) | Formulación y método antidiabético | |
| ES2186693T3 (es) | Uso combinado del acido hialuronico y de agentes terapeuticos para mejorar el efecto terapeutico. | |
| ATE111733T1 (de) | Verwendung von nikotin zur herstellung eines kit zur behandlung von krankheitszuständen, die auf eine nikotinbehandlung ansprechen. | |
| CA2041579A1 (en) | Dosage form | |
| DE69003392D1 (de) | Dosisform zur oralen verabreichung des hypoglykämischen glipizids. | |
| DE799037T1 (de) | Verfahren und mittel zur behandlung der allergischen rhinitis und anderer erkrankungen mittels descarboethoxyloratadin | |
| JP2002532432A5 (de) | ||
| NO920855D0 (no) | Medikamentinneholdende matrise | |
| IL112288A (en) | Use of riluzole in the manufacture of a medicament for the treatment of mitochondrial diseases | |
| ATE89737T1 (de) | Behandlung von leukozytstoerungen mit gm-csf. | |
| GR3032224T3 (en) | Therapeutic agent for threatened abortion. | |
| DE69007065D1 (de) | Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten. | |
| Duhault et al. | The pharmacology of S 1702, a new highly effective oral antidiabetic drug with unusual properties. 2. Protective activity of S 1702 on the microvascular system in normal and diabetic rats | |
| RU94018748A (ru) | Лекарственный сбор для лечения больных с нарушениями сердечного ритма | |
| EP0397211A3 (de) | Perkutane Verabreichung von 3'-Azido-3'-Deoxythymidin | |
| RU94000695A (ru) | Средство с противоаллергическим действием | |
| CN2233753Y (zh) | 护心袋 | |
| Reynolds et al. | Circulatory versus respiratory deaths from pentothal sodium | |
| CN2224631Y (zh) | 药物保健袋 | |
| RU93034374A (ru) | Лекарственный сбор для лечения ишемической болезни сердца, сопровождающейся выраженными невротическими реакциями | |
| 王小马 | ELECTROIMPULSE ACUPUNCTURE TREATMENT OF 110 CASES OF ABDOMINAL PAIN AS A SEOUELA OF ABDOMINAL SURGERY | |
| Katel'nitskaia et al. | Lipid peroxidation as an indicator of the effectiveness of treating patients with chronic ischemic heart disease using a helium-neon laser |